BOSTON - The judge supervising pharmaceutical average wholesale price (AWP) litigation granted partial summary judgment to governmental plaintiffs yesterday in the U.S. District Court for the District of Massachusetts and denied the summary judgment motions of 13 manufacturers of generic drugs (In Re Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, No. 01-12257, The City of New York, et al. v Abbott Laboratories, et al., No. 03-10643, D. Mass.). From Mealey's Emerging Drugs & Devices

SAN FRANCISCO - A California federal judge on Jan. 20 dismissed some claims by parents of a boy who contracted fatal hepatosplenic T-Cell lymphoma after being given three drugs, including Abbott Laboratories' Humira, to treat inflammatory bowel disease, but allowed the parents to file an amended complaint (Stephen Wendell, et al. v. Johnson & Johnson, et al., No. 09-04124, N.D. Calif.; 2010 U.S. Dist. LEXIS 4188). From Mealey's Litigation Report: Arthritis Drugs